How cells decide to become a placenta or a baby
Signaling-regulated establishment of pluripotency in vivo
['FUNDING_R01'] · MICHIGAN STATE UNIVERSITY · NIH-11105944
This research explores how a very early embryo decides which cells will form the placenta and which will become the baby.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICHIGAN STATE UNIVERSITY (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11105944 on ClinicalTrials.gov |
What this research studies
Our bodies begin as a tiny ball of cells, and this research looks at how these cells make their very first important decisions. We are learning how some cells are directed to become the placenta, which supports the baby, while others are set aside to become the baby itself. This involves understanding specific signals and factors, like SOX2, that guide these cells to become "pluripotent," meaning they have the potential to develop into any cell type in the body. By studying these fundamental processes, we hope to better understand the earliest stages of human development.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients but could inform future studies relevant to individuals interested in fertility, early development, or stem cell therapies.
Not a fit: Patients seeking immediate treatment for existing conditions would not directly benefit from this basic science research.
Why it matters
Potential benefit: Understanding these early developmental steps could lead to new insights into reproductive health, infertility, and regenerative medicine in the future.
How similar studies have performed: While the specific mechanism of SOX2 in pluripotency is a new discovery by this lab, the broader understanding of early embryonic cell fate decisions has been built upon decades of successful research.
Where this research is happening
EAST LANSING, UNITED STATES
- MICHIGAN STATE UNIVERSITY — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RALSTON, AMY — MICHIGAN STATE UNIVERSITY
- Study coordinator: RALSTON, AMY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.